- Home
- NLSP vs RCAT Comparison
NLSP vs RCAT Comparison
Compare NLSP & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- RCAT
- Stock Information
- Founded
- NLSP 2015
- RCAT 2002
- Country
- NLSP Switzerland
- RCAT United States
- Employees
- NLSP N/A
- RCAT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- RCAT Wholesale Distributors
- Sector
- NLSP Health Care
- RCAT Industrials
- Exchange
- NLSP Nasdaq
- RCAT Nasdaq
- Market Cap
- NLSP 12.4M
- RCAT N/A
- IPO Year
- NLSP 2021
- RCAT 2017
- Fundamental
- Price
- NLSP $2.57
- RCAT $7.14
- Analyst Decision
- NLSP
- RCAT Buy
- Analyst Count
- NLSP 0
- RCAT 1
- Target Price
- NLSP N/A
- RCAT $13.00
- AVG Volume (30 Days)
- NLSP 396.2K
- RCAT 11.2M
- Earning Date
- NLSP 07-15-2025
- RCAT 08-07-2025
- Dividend Yield
- NLSP N/A
- RCAT N/A
- EPS Growth
- NLSP N/A
- RCAT N/A
- EPS
- NLSP N/A
- RCAT N/A
- Revenue
- NLSP N/A
- RCAT $2,291,089.00
- Revenue This Year
- NLSP N/A
- RCAT $1,023.35
- Revenue Next Year
- NLSP N/A
- RCAT $88.95
- P/E Ratio
- NLSP N/A
- RCAT N/A
- Revenue Growth
- NLSP N/A
- RCAT N/A
- 52 Week Low
- NLSP $1.30
- RCAT $1.10
- 52 Week High
- NLSP $15.59
- RCAT $15.27
- Technical
- Relative Strength Index (RSI)
- NLSP 57.00
- RCAT 49.05
- Support Level
- NLSP $2.51
- RCAT $6.98
- Resistance Level
- NLSP $3.08
- RCAT $7.54
- Average True Range (ATR)
- NLSP 0.23
- RCAT 0.68
- MACD
- NLSP 0.02
- RCAT -0.14
- Stochastic Oscillator
- NLSP 44.41
- RCAT 17.54
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.